Hua Xia Healthcare Holdings Limited provided earnings guidance for the year ended March 31, 2013. For the period, the group is expected to record a lowered profit attributable to the shareholders of about 40% to 60% compared to that of the year ended March 31, 2013, which is mainly due to proportionate reduction of the Company's equity interest in the pharmaceutical wholesale and pharmaceutical retail business operated under the Wanjia Group which in turn results in reduction of the profit attributable to the shareholders; the increase of expenses incurred for the proposed spin-off and thedistribution, and the loss on early redemption of promissory note.